The Susan G Komen Tissue Bank at the IU Simon Cancer Center A Collection and Storage of Biological Specimens Intended for use in the Elucidation of Breast Carcinogenesis
M
Michele Cote
Primary Investigator
Recruiting
18-100 years
All
Phase
N/A
10000 participants needed
1 Location
Brief description of study
Would you like to contribute to the fight against breast cancer? You can help by donating a breast tissue sample during an event at the IU Melvin and Bren Comprehensive Cancer Center from 8 am to 2 pm on October 19th, 2024. While the donation process takes only 60-90 minutes, your
contribution could help cancer researchers make lasting discoveries.
What is the purpose of this study?
The Susan G. Komen® Tissue Bank (Komen Tissue Bank, or KTB),
established by
researchers at the Indiana University Melvin and Bren Simon Comprehensive
Cancer Center and Indiana University School of Medicine, is the world's first
and only repository containing breast tissue and blood products from individuals
who do not currently show signs of breast cancer. Our most valuable specimens
are healthy breast tissue. By collecting samples from women and men without
breast cancer, researchers may be able to better understand the differences
between healthy and cancerous tissue, which could lead to breakthroughs in
understanding the disease
Who can take part in this study?
We are looking to obtain and store specimens (tissue, blood, and
saliva) from adults (ages 18 and older) who have not been diagnosed with breast
cancer and breast cancer survivors who have an unaffected breast.
Additional information
Study title: The Susan G. Komen for a Cure Tissue Bank at IU Simon Cancer Center Collection and Storage of Biological Specimens Intended for Use in the Elucidation of Breast Carcinogenesis
The KTB hosts collection event 2-3 times a year, with at least one
here is Indianapolis.
Our next collection event in 2024 is October 19th at the IU Simon Comprehensive Cancer Center.
Our 2025 events will be announced soon.
Detailed description of study
What to expect during the donation process
- Prior to the donation, participants will complete an informed consent document and an online questionnaire, height and weight measurements will be taken, and a blood sample will be taken.
- Physicians, staff, and volunteers from the Komen Tissue Bank will collect the tissue samples for this breast cancer clinical trial.
- During the donation process, a tissue sample is taken from one breast with a needle and local anesthesia.
- The amount of tissue taken is about one gram (or the size of two peas).
- The entire process usually takes 60 to 90 minutes.
Incentive/compensation
- Participants will receive parking validations or other transportation (i.e., metro card) for events where there is not free parking.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Healthy, Breast Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
- Have the ability to understand and the willingness to sign an informed consent (no signs of dementia or any psychiatric conditions that would not allow the understanding or rendering of informed consent.
- Be willing to give one hour of your time to complete a questionnaire and a breast biopsy
- Allergic to local anesthetics (numbing medicine).
- Currently receiving a therapeutic blood thinner (this does not include aspirin).
- Have breast implants.
- Individuals currently undergoing or have previously undergone medical/surgical transitioning to a gender not previously assigned at birth.
- The breast intended for tissue donation cannot have had prior therapeutic radiation.
- Has undergone radiation to the whole chest wall.
- Any other condition, which in the opinion of the physician performing the biopsy procedure would make participation in this protocol unreasonably hazardous for the participant.
Updated on
23 Sep 2024.
Study ID: IUCRO-0209, 1011003097 (0709-17)
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
